Search Results
55 items found for "Zhan-Guo Gao"
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
and anxiety, has shown, in the last decade, increasing evidence of its antitumoral properties in more than
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
In fact, it is often costly, frustrating, and tortuous—and more often than not it ends in failure.
- Structures of β 1-adrenergic receptor in complex with Gs and ligands of different efficacies
intermediate state complex comprising β1-AR and nucleotide-free Gs is more stable when binding a full agonist than
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
Six compounds showed more than 50% displacement of the radioligand at 10 µM concentration with compound
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
He has led teams that have filed more than 10 Investigational New Drug Applications (IND), as well as
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
However, our predictions were many folds shorter than those determined experimentally.
- VAMP2: a crucial player in the delivery of MOR to the synapse
Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013. Zhang, and L. Ma. 2008.
- Delineation of GPR15 receptor-mediated Gα protein signaling profile in recombinant mammalian cell
The results show that the GPR15 receptor preferentially couples to Gi/o rather than other pathways in
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
C5aR2 is a nonclassical GPCR that tailors immune cell activity potentially through β-arrestins rather than
- Design and validation of recombinant protein standards for quantitative Western blot analysis of...
density obtained by quantitative Western blot were of the same order of magnitude but slightly higher than
- Comparative studies of AlphaFold, RoseTTAFold and Modeller: a case study involving the use of...
program's top-scored structure, Modeller had the smallest average modeling RMSD of 2.17 Å, which is better than
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
was highly expressed in breast cancers, and patients harboring altered GASP1 showed a worse prognosis than
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
It is predicted that more than 50 GPCRs are expressed in the liver.
- Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...
Because there are many more GPCRs than effectors, mutations in different receptors could perturb signaling
- Platelets in the NETworks interweaving inflammation and thrombosis
In light of the current COVID-19 pandemic, the topic of immunothrombosis has become more relevant than
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
internalize both receptors whereas pasireotide promoted robust receptor internalization at shorter times than
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
These receptors have much larger binding pockets than the majority of GPCRs that have been successfully ’ interaction ensures that all molecules in the library are specific for the target receptor rather than either G protein signaling or arrestin signaling, and superagonists with signaling activity higher than conjugate exhibited poor selectivity for CCR5-expressing cells and was less effective at killing cells than Orion’s CCR2 antagonist analog (OB-004), discovered in only 6 months, is considerably more potent than
- Do You Believe AI Could Accelerate Drug Discovery?
Of 161 molecules tested, 42 substituted more than 50% of [³H]-LSD at 10 μM, achieving a 26% hit rate.
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
of GPCR activation has always been a challenge because G protein activation in cells occurs in less than
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
suggesting that the selectivity of the G-protein lies in intrinsic features of the receptor rather than
- Therapeutic validation of an orphan G protein‐coupled receptor
., 2016; Zhang et al., 2016) and embelin (2,5‐dihydroxy‐3‐undecyl‐1,4‐benzoquinone) which is a natural
- Chemokine receptor-targeted drug discovery: progress and challenges
overexpressed and promote cancer progression, and use promiscuous non-peptide antagonists able to target more than
- 📰 GPCR Weekly News, July 1 to 7, 2024
Jianming Han , Tao Che for their analysis of GPCR-G protein selectivity revealed by structural pharmacology Submit your abstract today; you have less than two weeks!
- 📰 GPCR Weekly News, June 17 to 23, 2024
Epilepsy Models Biophysicists decipher functionality of adrenaline-binding receptor Tectonic plates more than
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Zhao, P., et al., Activation of the GLP-1 receptor by a non-peptidic agonist.
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
., Zhang, L., Corriden, R., Liu, D., Feigin, M. E., French, R. P., Lowy, A.
- Ode to GPCRs
Zhang, X. & Eggert, U. S.